Medical technology company, Sky Medical, honored with King's Award for enterprise innovation, due to their groundbreaking geko device.
In the realm of global healthcare, chronic wounds continue to pose a significant challenge, racking up billions in costs for healthcare systems annually. However, a new standard in chronic wound management is emerging, and it's making waves with its FDA clearance, NICE guidance, and integration across NHS Trusts and international health systems.
Enter the Geko device, a groundbreaking innovation from Sky Medical Technology, a UK-based medical device innovator and manufacturer. The Geko device has been awarded the King's Award for Enterprise in Innovation, joining an exclusive group of 197 organizations to receive this prestigious honour this year.
The success of the Geko device is not merely a fleeting trend. It delivers real-world value clinically, operationally, and economically, as attested by Fiona Young, Firstkind Wound Therapy Business Director. The device is particularly effective in engaging patients and keeping them on protocol, ensuring the healing process remains uninterrupted.
The momentum of the Geko device stems from robust clinical evidence, strong day-to-day outcomes in practice, and rapidly escalating adoption across multiple NHS primary care clinics. In fact, the number of prescriptions for the Geko device is increasing by over 60% quarter-over-quarter for the last 3 consecutive quarters.
The Geko device addresses the unmet need for a clinically validated, non-invasive therapy in wound care. Using its proprietary neuromuscular electrostimulation technology, the device increases lower limb blood flow, accelerating healing and recovery. Remarkably, the Geko device is clinically proven to more than double the rate of wound healing.
Q1 sales results for the Geko device are over budget, a testament to its growing popularity and effectiveness. The device is driving a transformation in chronic wound care and enabling scalable, cost-effective healthcare delivery across major markets.
While the broader landscape of non-invasive wound healing is evolving rapidly with sensor integration, optimized light therapies, and enhanced topical delivery systems contributing to improved outcomes, the Geko device remains a standout innovation. Clinicians are reporting an immediate reduction in pain when using the Geko device, and the rapid effect on healing is being observed with its use.
For those seeking detailed, up-to-date information on the Geko device's latest advancements or clinical evidence, consulting Sky Medical Technology's official releases or clinical trial registries would be recommended. The Geko device continues to redefine the future of chronic wound care, offering a beacon of hope for patients and healthcare providers alike.
[1] SnapshotNIR technology [2] Photobiomodulation using blue light [3] Topical drug delivery [4] Wearable wound monitoring device [5] Laser-assisted non-invasive drug delivery pathways (Sources not provided in the given information)
Medical plastics, such as those used in the Geko device, play a crucial role in patient care by providing durable and safe components for medical-conditions management, like chronic wounds. The success and adoption of the Geko device in healthcare systems, driven by its technological advancements in neuromuscular electrostimulation, have opened new avenues in health-and-wellness, making significant improvements in chronic-diseases management. This innovative device from Sky Medical Technology exemplifies the integration of science and technology to enhance medical-conditions treatment, setting new standards in health-and-wellness.
